Medicaid Managed Care Policies & Procedures Archive - Pharmacy (2026)

"Policy or procedure" shall mean a requirement governing the administration of managed care organizations specific to billing guidelines, medical management and utilization review guidelines, case management guidelines, claims processing guidelines and edits, grievance and appeals procedures and process, other guidelines or manuals containing pertinent information related to operations and pre-processing claims, and core benefits and services.

Below are items previously posted for public comment:

Item Number Policy/Procedure Date Posted Comment Period Closed Status Document Links
2026-ACLA-MED-129 Papzimeos 2/27/26 4/13/26 Complete Papzimeos
2026-LHCC-MED-904 Valrubicin (Valstar) 2/9/26 3/26/26 Complete Valrubicin (Valstar)
2026-LHCC-MED-905 Tafasitamab-cxix (Monjuvi) 2/9/26 3/26/26 Complete Tafasitamab-cxix (Monjuvi)
2026-LHCC-MED-906 Irinotecan Liposome (Onivyde) 2/9/26 3/26/26 Complete Irinotecan Liposome (Onivyde)
2026-LHCC-MED-907 Levoleucovorin (Fusilev, Khapzory) 2/9/26 3/26/26 Complete Levoleucovorin (Fusilev, Khapzory)
2026-LHCC-MED-908 Eribulin Mesylate (Halaven) 2/9/26 3/26/26 Complete Eribulin Mesylate (Halaven)
2026-LHCC-MED-909 Daunorubicin/Cytarabine (Vyxeos) 2/9/26 3/26/26 Complete Daunorubicin/Cytarabine (Vyxeos)
2026-LHCC-MED-910 Leucovorin Injection 2/9/26 3/26/26 Complete Leucovorin Injection
2026-LHCC-MED-911 Tofersen (Qalsody) 2/9/26 3/26/26 Complete Tofersen (Qalsody)
2026-LHCC-MED-912 Obinutuzumab (Gazyva) 2/9/26 3/26/26 Complete Obinutuzumab (Gazyva)
2026-LHCC-MED-913 Pralatrexate (Folotyn) 2/9/26 3/26/26 Complete Pralatrexate (Folotyn)
2026-LHCC-MED-914 Antithymocyte Globulin (Atgam, Thymoglobulin) 2/9/26 3/26/26 Complete Antithymocyte Globulin (Atgam, Thymoglobulin)
2026-LHCC-MED-915 Inotuzumab Ozogamicin (Besponsa) 2/9/26 3/26/26 Complete Inotuzumab Ozogamicin (Besponsa)
2026-LHCC-MED-916 Tisotumab Vedotin-tftv (Tivdak) 2/9/26 3/26/26 Complete Tisotumab Vedotin-tftv (Tivdak)
2026-LHCC-MED-917 Ofatumumab (Arzerra) 2/9/26 3/26/26 Complete Ofatumumab (Arzerra)
2026-LHCC-MED-886 Avacincaptad pegol (Izervay) 2/9/26 3/26/26 Complete Avacincaptad pegol (Izervay)
2026-LHCC-MED-887 Asfotase Alfa (Strensiq) 2/9/26 3/26/26 Complete Asfotase Alfa (Strensiq)
2026-LHCC-MED-888 Azacitidine (Onureg, Vidaza) 2/9/26 3/26/26 Complete Azacitidine (Onureg, Vidaza)
2026-LHCC-MED-889 Ravulizumab-cwvz (Ultomiris) 2/9/26 3/26/26 Complete Ravulizumab-cwvz (Ultomiris)
2026-LHCC-MED-890 Cetuximab (Erbitux) 2/9/26 3/26/26 Complete Cetuximab (Erbitux)
2026-LHCC-MED-891 Carfilzomib (Kyprolis) 2/9/26 3/26/26 Complete Carfilzomib (Kyprolis)
2026-LHCC-MED-892 Bendamustine (Belrapzo, Bendeka, Treanda, Vivimusta) 2/9/26 3/26/26 Complete Bendamustine (Belrapzo, Bendeka, Treanda, Vivimusta)
2026-LHCC-MED-893 Rozanolixizumab-noli (Rystiggo) 2/9/26 3/26/26 Complete Rozanolixizumab-noli (Rystiggo)
2026-LHCC-MED-894 Talquetamab-tgvs (Talvey) 2/9/26 3/26/26 Complete Talquetamab-tgvs (Talvey)
2026-LHCC-MED-895 Elranatamab-bcmm (Elrexfio) 2/9/26 3/26/26 Complete Elranatamab-bcmm (Elrexfio)
2026-LHCC-MED-896 Melphalan (Hepzato) 2/9/26 3/26/26 Complete Melphalan (Hepzato)
2026-LHCC-MED-873 Mogamulizumab-kpkc (Poteligeo) 2/9/26 3/26/26 Complete Mogamulizumab-kpkc (Poteligeo)
2026-LHCC-MED-874 Pasireotide (Signifor, Signifor LAR) 2/9/26 3/26/26 Complete Pasireotide (Signifor, Signifor LAR)
2026-LHCC-MED-875 Pegvisomant (Somavert) 2/9/26 3/26/26 Complete Pegvisomant (Somavert)
2026-LHCC-MED-876 Lanreotide (Somatuline Depot) 2/9/26 3/26/26 Complete Lanreotide (Somatuline Depot)
2026-LHCC-MED-877 Belatacept (Nulojix) 2/9/26 3/26/26 Complete Belatacept (Nulojix)
2026-LHCC-MED-878 Necitumumab (Portrazza) 2/9/26 3/26/26 Complete Necitumumab (Portrazza)
2026-LHCC-MED-879 Ziv-aflibercept (Zaltrap) 2/9/26 3/26/26 Complete Ziv-aflibercept (Zaltrap)
2026-LHCC-MED-880 Plasminogen, Human-tvmh (Ryplazim) 2/9/26 3/26/26 Complete Plasminogen, Human-tvmh (Ryplazim)
2026-LHCC-MED-881 Belinostat (Beleodaq) 2/9/26 3/26/26 Complete Belinostat (Beleodaq)
2026-LHCC-MED-882 Romidepsin (Istodax) 2/9/26 3/26/26 Complete Romidepsin (Istodax)
2026-LHCC-MED-883 Temsirolimus (Torisel) 2/9/26 3/26/26 Complete Temsirolimus (Torisel)
2026-LHCC-MED-884 Pegaspargase (Oncaspar), Calaspargase Pegol-mknl 2/9/26 3/26/26 Complete Pegaspargase (Oncaspar), Calaspargase Pegol-mknl
2026-LHCC-MED-885 Denileukin Diftitox-cxdl (Lymphir) 2/9/26 3/26/26 Complete Denileukin Diftitox-cxdl (Lymphir)
2026-LHCC-MED-872 Zopapogene Imadenovec (Papzimeos) 2/6/26 3/23/26 Complete Zopapogene Imadenovec (Papzimeos)
2026-LHCC-MED-897 Brexucabtagene Autoleucel (Tecartus) 2/6/26 3/23/26 Complete Brexucabtagene Autoleucel (Tecartus)
2026-LHCC-MED-898 Talimogene laherepvec (Imlygic) 2/6/26 3/23/26 Complete Talimogene laherepvec (Imlygic)
2026-LHCC-MED-899 Trastuzumab/Biosimilars, Trastuzumab-Hyaluronidase 2/6/26 3/23/26 Complete Trastuzumab/Biosimilars, Trastuzumab-Hyaluronidase
2026-LHCC-MED-900 Atezolizumab (Tecentriq) 2/6/26 3/23/26 Complete Atezolizumab (Tecentriq)
2026-LHCC-MED-901 Pemetrexed (Alimta, Pemfexy) 2/6/26 3/23/26 Complete Pemetrexed (Alimta, Pemfexy)
2026-LHCC-MED-902 Cemiplimab-rwlc (Libtayo) 2/6/26 3/23/26 Complete Cemiplimab-rwlc (Libtayo)
2026-LHCC-MED-903 Motixafortide (Aphexda) 2/6/26 3/23/26 Complete Motixafortide (Aphexda)
2026-ACLA-MED-128 VEGF Inhibitors 2/6/26 3/23/26 Complete VEGF Inhibitors
2026-PHARM-6 Asthma/COPD - Immunomodulators 2/6/26 3/23/26 Complete Asthma/COPD - Immunomodulators
2026-PHARM-7 Avtozma 2/6/26 3/23/26 Complete Avtozma
2026-PHARM-8 Brinsupri 2/6/26 3/23/26 Complete Brinsupri
2026-PHARM-9 Casgevy 2/6/26 3/23/26 Complete Casgevy
2026-PHARM-10 Dawnzera 2/6/26 3/23/26 Complete Dawnzera
2026-PHARM-11 Ekterly 2/6/26 3/23/26 Complete Ekterly
2026-PHARM-12 Exxua 2/6/26 3/23/26 Complete Exxua
2026-PHARM-13 Heart Disease - Hyperlipidemia, Lipotropics Other 2/6/26 3/23/26 Complete Heart Disease - Hyperlipidemia, Lipotropics Other
2026-PHARM-14 Jascayd 2/6/26 3/23/26 Complete Jascayd
2026-PHARM-15 Louisiana Medicaid ICD-10 Chart 2/6/26 3/23/26 Complete Louisiana Medicaid ICD-10 Chart
2026-PHARM-16 Nypozi 2/6/26 3/23/26 Complete Nypozi
2026-PHARM-17 Oncology Agents - Oral Other 2/6/26 3/23/26 Complete Oncology Agents - Oral Other
2026-PHARM-18 Pain Management - Antimigraine Agents, CGRP Antagonists 2/6/26 3/23/26 Complete Pain Management - Antimigraine Agents, CGRP Antagonists
2026-PHARM-19 Pain Management - Cytokine/CAM Antagonists 2/6/26 3/23/26 Complete Pain Management - Cytokine/CAM Antagonists
2026-PHARM-20 Pain Management - Skeletal Muscle Relaxants 2/6/26 3/23/26 Complete Pain Management - Skeletal Muscle Relaxants
2026-PHARM-21 POS Anzupgo 2/6/26 3/23/26 Complete POS Anzupgo
2026-PHARM-22 POS Asthma/COPD - Immunomodulators 2/6/26 3/23/26 Complete POS Asthma/COPD - Immunomodulators
2026-PHARM-23 POS Brinsupri 2/6/26 3/23/26 Complete POS Brinsupri
2026-PHARM-24 POS Dermatology - Antipsoriatics, Topical 2/6/26 3/23/26 Complete POS Dermatology - Antipsoriatics, Topical
2026-PHARM-25 POS Empaveli 2/6/26 3/23/26 Complete POS Empaveli
2026-PHARM-26 POS Exxua 2/6/26 3/23/26 Complete POS Exxua
2026-PHARM-27 POS Heart Disease - Hyperlipidemia, Anticoagulants 2/6/26 3/23/26 Complete POS Heart Disease - Hyperlipidemia, Anticoagulants
2026-PHARM-28 POS Jascayd 2/6/26 3/23/26 Complete POS Jascayd
2026-PHARM-29 POS Kirsty 2/6/26 3/23/26 Complete POS Kirsty
2026-PHARM-30 POS Oncology - Oral Other 2/6/26 3/23/26 Complete POS Oncology - Oral Other
2026-PHARM-31 POS Pain Management - Skeletal Muscle Relaxants 2/6/26 3/23/26 Complete POS Pain Management - Skeletal Muscle Relaxants
2026-PHARM-32 POS Rhapsido 2/6/26 3/23/26 Complete POS Rhapsido
2026-PHARM-33 POS Zurnai 2/6/26 3/23/26 Complete POS Zurnai
2026-PHARM-34 Rhapsido 2/6/26 3/23/26 Complete Rhapsido
2026-PHARM-35 Sephience 2/6/26 3/23/26 Complete Sephience
2026-PHARM-36 Tyruko 2/6/26 3/23/26 Complete Tyruko
2026-PHARM-37 Vyjuvek 2/6/26 3/23/26 Complete Vyjuvek
2026-PHARM-5 Max Dose Override Buprenorphine 2/2/26 3/19/26 Complete Max Dose Override Buprenorphine
2026-PHARM-1 Wegovy 1/16/26 3/2/26 Complete Wegovy
2026-PHARM-2 POS Wegovy 1/16/26 3/2/26 Complete POS Wegovy
2026-PHARM-3 Max Dose Override Buprenorphine 1/16/26 3/2/26 Complete Max Dose Override Buprenorphine
2026-PHARM-4 POS Opiate Dependence Agents 1/16/26 3/2/26 Complete POS Opiate Dependence Agents
2026-HB-MED-647 Rebyota (fecal microbiota, live – jslm) 1/7/26 2/21/26 Complete Rebyota (fecal microbiota, live – jslm)
2026-HB-MED-648 Zinplava (bezlotoxumab) 1/7/26 2/21/26 Complete Zinplava (bezlotoxumab)
2026-HB-MED-649 Xiaflex (collagenase clostridium histolyticum) 1/7/26 2/21/26 Complete Xiaflex (collagenase clostridium histolyticum)
2026-HB-MED-650 Crysvita (burosumab-twza) 1/7/26 2/21/26 Complete Crysvita (burosumab-twza)
2026-HB-MED-651 Veopoz (pozelimab-bbfg) 1/7/26 2/21/26 Complete Veopoz (pozelimab-bbfg)
2026-HB-MED-652 Nexobrid (anacaulase-bcdb) 1/7/26 2/21/26 Complete Nexobrid (anacaulase-bcdb)
2026-HB-MED-653 Gamifant (emapalumab-lzsg) 1/7/26 2/21/26 Complete Gamifant (emapalumab-lzsg)
2026-HB-MED-654 Prostacyclin Infusion and Inhalation Therapy  1/7/26 2/21/26 Complete Prostacyclin Infusion and Inhalation Therapy 
2026-HB-MED-655 Scenesse (afamelanotide)  1/7/26 2/21/26 Complete Scenesse (afamelanotide) 

Surgeon General Evelyn Griffin, MD

Secretary Bruce D. Greenstein

Powered by Cicero Government